Xeris Pharmaceuticals | Actif À Court Terme


Current Assets Changement Date
Adcock Ingram Holdings ZAR 5.12B 234.71M 2024-12
Celltrion KRW 5.46T 122.95B 2025-03
Cspc Pharmaceutical CNY 21.89B 4.58B 2024-12
Dianthus Therapeutics USD 263.6M 17.3M 2025-06
Divis Laboratories Ltd 100.81B 7.4B 2025-03
Eli Lilly USD 49.85B 8.59B 2025-06
Kangmei Pharma CNY 6.9B 6.92M 2025-06
Knight Therapeutics CAD 397.57M 36.96M 2024-09
Laboratorios Farma EUR 516.3M 26.69M 2025-06
Malin Corporation EUR 62.6M 26.7M 2024-12
Medical Developments International AUD 33.41M 7.26M 2024-12
Neuren Pharmaceuticals AUD 399.33M 171.29M 2024-12
Organigram Holdings CAD 277.78M 46.29M 2025-06
Pacira USD 745.61M 14.35M 2025-06
Perrigo USD 2.62B 82M 2025-06
Pharma Mar EUR 249.4M 13.39M 2025-06
Qiagen NV USD 1.82B 76.12M 2025-06
Sartorius EUR 2.17B 7.5M 2025-06
Sino Biopharmaceutical CNY 24.69B 536.66M 2024-12
Supernus Pharmaceuticals USD 738.87M 51.28M 2025-06
Tilray USD 707.34M 18.54M 2024-11
Zz Pientze Pharmaceu 12.29B 113.34M 2025-06


Xeris Pharmaceuticals Actif À Court Terme - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Sep 2025.